Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1279 | 1057 | 1279 | 1100 | 1614 | 3187 |
Fund Return | 27.89% | 5.72% | 27.89% | 3.24% | 10.04% | 12.29% |
Place in category | - | - | - | - | - | - |
% in Category | - | - | - | - | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
RBC Canadian Div Fund Series F CAD | 22.86B | 18.40 | 8.14 | 8.24 | ||
RBC Canadian Dividend Fund Series I | 22.86B | 18.70 | 8.42 | 8.53 | ||
RBC Canadian Div Fund Series D CAD | 22.86B | 18.08 | 7.84 | 7.93 | ||
RBC Sel Gr Port Sr F CAD | 17.8B | 17.46 | 5.01 | 7.85 | ||
RBC Sel Gr Port Sr T5 | 17.8B | 16.29 | 3.96 | 6.75 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity Global Innovators Class F | 16.83B | 60.55 | 18.32 | - | ||
Capital Group Glbal Equity Fd F CAD | 13.87B | 28.47 | 5.35 | 11.90 | ||
Capital Group Glbal Equity Fd A CAD | 13.87B | 27.06 | 4.20 | 10.67 | ||
Capital Group Glbal Equity Fd D CAD | 13.87B | 28.08 | 5.00 | 11.43 | ||
Mawer Global Equity | 13.55B | 10.72 | 4.79 | 10.63 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 6.46 | 418.95 | -1.32% | |
Amazon.com | US0231351067 | 5.43 | 218.94 | -1.44% | |
NVIDIA | US67066G1040 | 5.35 | 135.91 | -3.00% | |
UnitedHealth | US91324P1021 | 4.52 | 520.69 | -0.73% | |
Safran | FR0000073272 | 3.64 | 216.10 | -1.95% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Neutral | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review